Últimas notícias Astrazeneca

As vacinas seguem agora para o Controle de Qualidade interno de Bio-Manguinhos, onde uma análise minuciosa irá garantir a sua integridade e segurança (foto: Bio-Manguinhos/Fiocruz)

Covid-19: all vaccines administered in Brazil are effective

The information is contained in the first edition of the bulletin on the effectiveness of vaccines against covid-19 in the Brazilian population, from the Vigivac project by Fiocruz, published on the 9th.

Vacina AstraZeneca

Fiocruz delivers 2.8 million doses of AstraZeneca

To date, the National Immunization Program has received 144.2 million doses of Oxford-AstraZeneca vaccine. In November there were 23.2 million.

O ministro Marcelo Queiroga participou, na manhã de hoje, da assinatura de termo de intenção de compra firmado entre a Fiocruz e a AstraZeneca, que vai garantir IFA suficiente para produzir 60 MILHÕES de doses no Brasil no próximo ano.

Friocruz, AstraZeneca ink deal to import API in 2022

The new batches of the API will make it possible for Fiocruz’s Rio-based Immuno-biological Technology Institute (Bio-Manguinhos) to manufacture 60 million doses of the vaccine against COVID-19 in 2022.

Vacina AstraZeneca

Fiocruz: Brazil API to undergo 14 tests in US

The process of producing the API is strictly controlled, encompassing 81 tests in all. The longest is said to last 56 days.

FILE PHOTO: Vials labelled

Brazil authorizes efficiency test for AstraZeneca booster shot

The initial study will be carried out in participants who have already received the two doses of the inoculation, with an interval of four week between administrations, Anvisa noted. The booster shot will be administered 11 to 13 months after the second dose.